Results
82
82 companies
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥52.9b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥31.55
7D
-1.0%
1Y
-3.4%
Tonghua Golden-Horse Pharmaceutical Industry CoLtd
Market Cap: CN¥21.7b
Engages in the research, development, manufacture, and sale of pharmaceutical products in China.
000766
CN¥23.29
7D
4.9%
1Y
64.9%
Sichuan Biokin PharmaceuticalLtd
Market Cap: CN¥118.8b
Engages in the research and development, production, and marketing of small molecule chemical, molecular biological, and antibody-drug conjugate drugs in China and internationally.
688506
CN¥312.56
7D
2.1%
1Y
80.5%
Yili Chuanning BiotechnologyLtd
Market Cap: CN¥27.4b
Engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally.
301301
CN¥12.40
7D
-0.5%
1Y
9.4%
Telix Pharmaceuticals
Market Cap: AU$5.6b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$17.13
7D
-7.8%
1Y
-7.1%
Pfizer
Market Cap: ₹233.4b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹5,107.00
7D
1.1%
1Y
-11.5%
Haw Par
Market Cap: S$3.1b
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.
H02
S$14.24
7D
1.1%
1Y
39.2%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥17.6b
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.
000403
CN¥18.23
7D
-1.8%
1Y
-5.5%
Grand Pharmaceutical Group
Market Cap: HK$28.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.29
7D
0.1%
1Y
83.8%
WuXi XDC Cayman
Market Cap: HK$68.9b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$61.95
7D
5.7%
1Y
250.8%